Kiniksa Pharmaceuticals International Plc (KNSA)
46.03
-1.24
(-2.62%)
USD |
NASDAQ |
Mar 05, 16:00
46.03
0.00 (0.00%)
After-Hours: 18:02
Kiniksa Pharmaceuticals International Research and Development Expense (Annual) : 96.66M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Marker Therapeutics, Inc. | 13.47M |
| NovoCure Ltd. | 224.54M |
| LivaNova Plc | 182.16M |
| Alterola Biotech, Inc. | -- |
| Akanda Corp. | -- |